Starting in 2017 and over 5 years, Huikang Bio-Tech plans to invest 50 million RMB to synthesize 175,000 peptides, and build a parallel peptide bank with clear sequence, named "China Peptide Bank".

The "China Peptide Bank" can be combined with any detection method to construct a screening platform for leading active epitope peptides in the field of biomedical research, thus supporting the transition from imitation to original R&D.

The "China Peptide Bank" contains a large number of unknown active epitope peptide information and is a treasure house shared by all mankind.  It can provide active peptides for screening in pharmaceutical, food, health care products, cosmetics, catalysts and materials industries. The value of future application is immeasurable. 

Epitope peptide, a small molecule peptide composed of several key amino acid residues is responsible for most of the binding energy between protein molecules.  Finding these epitope peptides is essential for restoring balance, helping cure disease.